INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-18-00003

Thrombogenicity at the jailed side branch ostia in the provisional stenting technique: insights from an in vitro model

Valeria Paradies1, MD; Shenjie Lu1, PhD; Jaryl Ng1, BEng; Huiying Ang1, PhD; Michael Joner2, MD, PhD; Nicolas Foin1,3*, MSc, PhD

Despite the considerable efforts made in developing techniques to optimise procedural success and long-term outcomes, bifurcation lesion PCIs are still associated with higher event rates than non-bifurcation interventions. Provisional stenting with stenting of the main vessel and optional side branch (SB) stenting is considered the gold standard approach, while the benefit of routine SB strut dilatation or kissing balloon inflation remains unclear.

Even though overhanging struts in front of the SB ostium are thought to act as a focal point for thrombi formation and consequently possible stent thrombosis, a direct causal effect between jailed struts and increased thrombogenicity has not yet been shown.

Metallic stents (XIENCE V®, n=1; 3.0×23 mm [Abbott Vascular, Santa Clara, CA, USA]; Resolute™, n=1; 3.5×33 mm [Medtronic, Minneapolis, MN, USA], and Integrity™, n=2; 3.0×18 mm [Medtronic]) were deployed in two different bifurcation silicone vessel models (proximal=3.5 mm, distal=2.75 mm and SB=2.75 mm, n=2; and proximal=4.5 mm, distal=3.5 mm and SB=3.0 mm, n=2) (Panel A), with proximal optimisation with 4.0 and 5.0 mm NC balloons (visually confirmed from OCT pullback) and then perfused with porcine blood at a rate of 200 m/min for four minutes1. Both OCT (Panel B) and immunofluorescence analysis with antiplatelet antibodies CD61 (Panel C) showed that the mean cross-sectional clot area at the bifurcation region was higher than at the proximal and distal regions (Panel D, Panel E).

In summary, in our model, struts floating at the SB orifice were shown to affect thrombus formation mechanism, but whether a similar mechanism may contribute to late SB compromise after DAPT discontinuation in clinical settings remains unknown.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 14 Number 7
Sep 20, 2018
Volume 14 Number 7
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV5I5A89 Nov 15, 2009
Optical coherence tomography assessment of a new dedicated bifurcation stent
Tyczynski P et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00794 Apr 6, 2018
Characteristics of stent thrombosis in bifurcation lesions analysed by optical coherence tomography
Bechiri M et al
free

State-of-the-Art Review

10.4244/EIJ-D-21-01065 Jul 22, 2022
Percutaneous coronary intervention of bifurcation lesions
Hildick-Smith D et al
free

Image – Interventional flashlight

10.4244/EIJ-D-20-00731 Aug 6, 2021
Periprocedural stent thrombosis after percutaneous coronary intervention for a bifurcation lipid-rich plaque
Häner JD et al
free
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
154.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
47.4

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
43.65

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved